One of the main factors that can influence your response to semaglutide is the presence of comorbidities, such as a history of early onset severe obesity, endocrine disorders, or developmental delays
Promising Results of APHD-012 The phase 2 trials of APHD-012 have shown promising results, significantly improving glucose tolerance in prediabetes patients
Data Last Updated 09/18/2025
Safety drives pacing
Snag custom swag, get priority scheduling, and save on our most popular treatments

Sources History's weirdest fad diets | BBC News Adult obesity facts | Centers for Disease Control and Prevention (CDC) Defining adult overweight & obesity | Centers for Disease Control and Prevention (CDC) CDCs division of nutrition, physical activity, and obesity | Centers for Disease Control and Prevention (CDC) Association of body mass index with health care expenditures in the United States by age and sex (2021) Ozempic | TikTok Diabetes and your eyes, heart, nerves, feet, and kidneys | National Kidney Foundation Ozempic (semaglutide) injection, for subcutaneous use (2017) Once-weekly semaglutide in adults with overweight or obesity (2021) Safety of semaglutide (2021) Havoc: Woman deprived of lifesaving drug because people want to lose weight | News.com.au Joint statement: Prioritisation of semaglutide (Ozempic) supply for people with type 2 diabetes during shortage | Therapeutic Goods Administration (TGA) Life's essential 8 - How to manage weight fact sheet | Heart Attack and Stroke Symptoms We make it easy for you to participate in a clinical trial for Weight management, and get access to the latest treatments not yet widely available - and be a part of finding a cure.
